On Friday, Inovio Pharmaceuticals Inc (NASDAQ: INO) opened higher 4.12% from the last session, before settling in for the closing price of $7.76. Price fluctuations for INO have ranged from $3.89 to $14.75 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 60.80% over the last five years. Company’s average yearly earnings per share was noted 27.34% at the time writing. With a float of $25.69 million, this company’s outstanding shares have now reached $25.91 million.
The firm has a total of 122 workers. Let’s measure their productivity.
Inovio Pharmaceuticals Inc (INO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Inovio Pharmaceuticals Inc is 0.84%, while institutional ownership is 17.03%.
Inovio Pharmaceuticals Inc (INO) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 3/31/2024, the company posted -1.56 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -1.74) by 0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.50% during the next five years compared to 13.49% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Check out the current performance indicators for Inovio Pharmaceuticals Inc (INO). In the past quarter, the stock posted a quick ratio of 4.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 290.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.53, a number that is poised to hit -1.10 in the next quarter and is forecasted to reach -3.19 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Analysing the last 5-days average volume posted by the [Inovio Pharmaceuticals Inc, INO], we can find that recorded value of 1.02 million was better than the volume posted last year of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 27.05%. Additionally, its Average True Range was 0.56.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 32.97%, which indicates a significant increase from 25.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.92% in the past 14 days, which was lower than the 86.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.25, while its 200-day Moving Average is $7.81. Now, the first resistance to watch is $8.36. This is followed by the second major resistance level at $8.64. The third major resistance level sits at $9.03. If the price goes on to break the first support level at $7.69, it is likely to go to the next support level at $7.30. Now, if the price goes above the second support level, the third support stands at $7.02.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
There are currently 25,911K shares outstanding in the company with a market cap of 209.35 million. Presently, the company’s annual sales total 830 K according to its annual income of -135,120 K. Last quarter, the company’s sales amounted to 100 K and its income totaled -25,000 K.
